Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Serum Glycomics as Prognostic and Diagnostic Biomarkers of Disease Recurrence in Liver Transplant Recipients With Hepatocellular Carcinoma

NCT05866783 is registered in ClinicalTrials.gov with University Hospital, Ghent as lead sponsor.

NCT NCT05866783
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05866783 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Serum Glycomics as Prognostic and Diagnostic Biomarkers of Disease Recurrence in Liver Transplant Recipients With Hepatocellular Carcinoma
Lead sponsor
University Hospital, Ghent
Phase
Observational
Overall status
Recruiting
Start date
April 28, 2023
Completion date
January 1, 2038
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diagnostic biomarker, hepatocellular carcinoma, liver transplantation, prognostic biomarker